<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8652017</article-id>
    <article-id pub-id-type="pmid">34726689</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btab731</article-id>
    <article-id pub-id-type="publisher-id">btab731</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Systems Biology</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Normalized coefficient of variation (nCV): a method to evaluate circadian clock robustness in population scale data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4526-2034</contrib-id>
        <name>
          <surname>Wu</surname>
          <given-names>Gang</given-names>
        </name>
        <aff><institution>Divisions of Human Genetics and Immunobiology, Center for Circadian Medicine, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center</institution>, Cincinnati, OH 45229, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Francey</surname>
          <given-names>Lauren J</given-names>
        </name>
        <aff><institution>Divisions of Human Genetics and Immunobiology, Center for Circadian Medicine, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center</institution>, Cincinnati, OH 45229, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ruben</surname>
          <given-names>Marc D</given-names>
        </name>
        <aff><institution>Divisions of Human Genetics and Immunobiology, Center for Circadian Medicine, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center</institution>, Cincinnati, OH 45229, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Hogenesch</surname>
          <given-names>John B</given-names>
        </name>
        <xref rid="btab731-cor1" ref-type="corresp"/>
        <aff><institution>Divisions of Human Genetics and Immunobiology, Center for Circadian Medicine, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center</institution>, Cincinnati, OH 45229, <country country="US">USA</country></aff>
        <!--john.hogenesch@cchmc.org-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Alkan</surname>
          <given-names>Can</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btab731-cor1">To whom correspondence should be addressed. <email>john.hogenesch@cchmc.org</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>01</day>
      <month>12</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-11-02">
      <day>02</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>02</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <volume>37</volume>
    <issue>23</issue>
    <fpage>4581</fpage>
    <lpage>4583</lpage>
    <history>
      <date date-type="received">
        <day>30</day>
        <month>7</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>22</day>
        <month>9</month>
        <year>2021</year>
      </date>
      <date date-type="editorial-decision">
        <day>13</day>
        <month>10</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>27</day>
        <month>10</month>
        <year>2021</year>
      </date>
      <date date-type="corrected-typeset">
        <day>10</day>
        <month>11</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btab731.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>Robust oscillation of clock genes is a core feature of the circadian system. Relative amplitude (rAMP) measures the robustness of clock gene oscillations but only works for longitudinal samples. We lack a method for estimating robust oscillations from human samples without labeled time. We show that the normalized coefficient of variation (nCV) of 10 clock genes is linearly correlated with their normalized rAMP, independent of time labels. We found that the mean nCV of clock genes are consistently decreased in tumors compared to nontumors, suggesting a new therapeutic target in cancer treatment by enhancing clock robustness. nCV can provide a simple measure of the clock robustness in population-level datasets.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>The nCV package (<ext-link xlink:href="https://github.com/gangwug/nCV" ext-link-type="uri">https://github.com/gangwug/nCV</ext-link>) and web application (<ext-link xlink:href="https://github.com/gangwug/nCVapp" ext-link-type="uri">https://github.com/gangwug/nCVapp</ext-link>) are available on the GitHub repository.</p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Cancer Institute</institution>
            <institution-id institution-id-type="DOI">10.13039/100000054</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>1R01CA227485-01A1</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institute of Neurological Disorders and Stroke</institution>
            <institution-id institution-id-type="DOI">10.13039/100000065</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>5R01NS054794-13</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Heart, Lung and Blood Institute</institution>
          </institution-wrap>
        </funding-source>
        <award-id>5R01HL138551-02</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>The feedback loop of the clock gene network drives robust clock gene oscillations (<xref rid="btab731-B5" ref-type="bibr">Gonze <italic toggle="yes">et al.</italic>, 2002</xref>; <xref rid="btab731-B11" ref-type="bibr">Ukai and Ueda, 2010</xref>). Clock gene knockouts (e.g. <italic toggle="yes">Arntl</italic>, <italic toggle="yes">Per1/2</italic> and <italic toggle="yes">Cry1/2</italic>) and disease states (e.g. cancers, metabolic syndrome and sleep disorders) can reduce (<xref rid="btab731-B1" ref-type="bibr">Anafi <italic toggle="yes">et al.</italic>, 2017</xref>; <xref rid="btab731-B2" ref-type="bibr">Bae <italic toggle="yes">et al.</italic>, 2001</xref>; <xref rid="btab731-B3" ref-type="bibr">Bunger <italic toggle="yes">et al.</italic>, 2000</xref>; <xref rid="btab731-B7" ref-type="bibr">Kume <italic toggle="yes">et al.</italic>, 1999</xref>) robustness of clock gene oscillations (hereafter referred to as clock gene robustness). Therefore, it is important to measure clock gene robustness, which can be thought of as relative amplitude (rAMP, the magnitude of the wave). The rAMP calculation requires time labeled samples (<xref rid="btab731-B13" ref-type="bibr">Wu <italic toggle="yes">et al.</italic>, 2020b</xref>). However, most human samples lack time information. There are currently no methods to directly estimate clock gene robustness in human samples when the time of collection is unknown.</p>
    <p>Here, we show that the normalized coefficient of variation (nCV) is linearly correlated with normalized rAMP for clock genes in longitudinal mouse and human datasets. Importantly, nCV can be applied to <italic toggle="yes">unordered</italic> datasets. Therefore, we applied nCV to analyze multiple cancer types and found that clock robustness is consistently reduced in tumors compared to adjacent nontumor samples.</p>
  </sec>
  <sec>
    <title>2 Materials and methods</title>
    <p>The rAMP is the ratio between amplitude and baseline (<xref rid="btab731-B13" ref-type="bibr">Wu <italic toggle="yes">et al.</italic>, 2020b</xref>), which are calculated by MetaCycle or CYCLOPS for each gene. The nrAMP is the ratio between the rAMP of a gene and the mean rAMP of all genes. The nCV is the ratio between the coefficient of variation (CV) of a clock gene and the mean CV of all genes. All datasets used in this study are available in the GEO database and FireBrowse (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). All statistical analyses were performed in R.</p>
  </sec>
  <sec>
    <title>3 Results</title>
    <p>Many lines of evidence suggest that the clock is dysregulated in cancer [reviewed in <xref rid="btab731-B8" ref-type="bibr">Sancar and Van Gelder (2021)</xref>]. Clock function is a network property that can be assessed by measuring phase relationships of multiple clock genes. On the other hand, clock gene robustness refers to the magnitude of circadian oscillation and is measured at the single-gene level by rAMP. rAMP indicates more robust circadian oscillation of <italic toggle="yes">ARNTL</italic> in normal human breast epithelial cells (MCF10A; rAMP = 0.085) compared to breast cancer cells (MCF7; rAMP = 0.003) (<xref rid="btab731-F1" ref-type="fig">Fig. 1A</xref>, left panel). The rAMP calculation requires the sample collection time (<xref rid="btab731-F1" ref-type="fig">Fig. 1A</xref>, right panel). However, the vast majority of patient datasets available do not have recorded collection times. Other metrics, such as the clock correlation distance (<xref rid="btab731-B10" ref-type="bibr">Shilts <italic toggle="yes">et al.</italic>, 2018</xref>), can indicate clock function in the absence of collection time, but cannot measure clock gene robustness (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref>). Therefore, we need a way to estimate clock gene robustness in population data where sampling time is not recorded.</p>
    <fig position="float" id="btab731-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>nCV measures clock robustness. (<bold>A</bold>) rAMP is uninformative when comparing human breast tumors versus adjacent nontumor samples without labeled time. nCV of 10 clock genes is linearly correlated with nrAMP in mouse tissues (<bold>B</bold>), in human prefrontal cortex samples with labeled time (<bold>C</bold>) and in CYCLOPS ordered human epidermis and dermis samples (<bold>D</bold>). (<bold>E</bold>) The mean nCV of 10 clock genes from nontumor (green) and tumor samples (purple) per dataset (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). Gray point represents the average value in nontumor or tumor group, with error bar indicating ±SD (Color version of this figure is available at <italic toggle="yes">Bioinformatics</italic> online.)</p>
      </caption>
      <graphic xlink:href="btab731f1" position="float"/>
    </fig>
    <p>To address this, we selected a group of 10 clock genes that: (i) are important in circadian regulation, (ii) cycle in multiple tissues, (iii) are phased across the full circadian cycle and (iv) represent a range of rAMP values (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>). Then, we searched for a time-independent measure of variance that is linearly correlated with rAMP. Median absolute deviation (MAD), standard deviation (SD) and the CV are common measures of transcript level variance. We found that the CV correlates with rAMP (<italic toggle="yes">r</italic> = 0.96) much better than with either MAD (<italic toggle="yes">r</italic> = 0.35) or SD (<italic toggle="yes">r</italic> = 0.37) for circadian genes in mouse liver (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S3</xref>). We used the normalized CV (nCV)to adjust for systemic differences in CV between datasets, and validated this new metric with the normalized rAMP (nrAMP) for a variety of datasets.</p>
    <p>The nCVs of the 10 clock genes show strong linear correlation (<italic toggle="yes">r</italic> = 0.94 and <italic toggle="yes">P</italic> &lt; 2.2e−16) to nrAMPs in 12 mouse tissues (<xref rid="btab731-F1" ref-type="fig">Fig. 1B</xref>). Importantly, the nCV is reduced in several genetic knockout models of the clock (<italic toggle="yes">Cry1</italic>/<italic toggle="yes">Cry2</italic> double knockout mouse livers; <italic toggle="yes">Arntl</italic> knockout cells and mouse tissues; <italic toggle="yes">Clock</italic> knockout mouse kidney; <italic toggle="yes">Nr1d1</italic>/<italic toggle="yes">Nr1d2</italic> double knockout mouse livers) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>). The mean nCV of 10 clock genes (hereafter referred to as clock robustness) in the knockout group is smaller (Wilcoxon test, <italic toggle="yes">P</italic> = 0.01) than the wild-type group (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S5</xref>). We next validated nCV in human samples with labeled time. nCV is strongly correlated with nrAMP in human prefrontal cortex samples (<xref rid="btab731-F1" ref-type="fig">Fig. 1C;</xref>  <italic toggle="yes">r</italic> = 0.96 and <italic toggle="yes">P</italic> = 1.5e−05) (<xref rid="btab731-B4" ref-type="bibr">Chen <italic toggle="yes">et al.</italic>, 2016</xref>) and human skin samples ordered by CYCLOPS (<xref rid="btab731-F1" ref-type="fig">Fig. 1D;</xref>  <italic toggle="yes">r</italic> = 0.98 and <italic toggle="yes">P</italic> = 2.4e−13) (<xref rid="btab731-B12" ref-type="bibr">Wu <italic toggle="yes">et al.</italic>, 2020a</xref>). In sum, nCV is a strong surrogate measure for nrAMP even when sample collection time is unknown.</p>
    <p>The vast majority of human datasets do not have time of day information available. This includes most cancer datasets. Thus, we applied nCV to study clock gene robustness in tumor versus adjacent nontumor samples without labeled time. The majority of clock genes showed reduced nCV in tumor samples from patients with hepatocellular carcinoma, lung adenocarcinoma, clear cell renal cell carcinoma, breast invasive carcinoma and thyroid carcinoma (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S6</xref>). The nCV of <italic toggle="yes">ARNTL</italic> and <italic toggle="yes">PER2</italic> is consistently decreased in tumor samples from all eight tested datasets. In sum, clock robustness is reduced in tumors compared to nontumors in all eight datasets (Wilcoxon test, <italic toggle="yes">P</italic> = 0.007; <xref rid="btab731-F1" ref-type="fig">Fig. 1E</xref>).</p>
    <p>Studies report inconsistent changes in clock gene expression between different human cancer types (<xref rid="btab731-B9" ref-type="bibr">Savvidis and Koutsilieris, 2012</xref>; <xref rid="btab731-B14" ref-type="bibr">Ye <italic toggle="yes">et al.</italic>, 2018</xref>). However, we show that clock robustness using nCV is consistently reduced across human cancers. Clock robustness may in fact be an important therapeutic target in cancer. For example, enhancing the circadian clock function in cancer cells inhibits tumor growth (<xref rid="btab731-B6" ref-type="bibr">Kiessling <italic toggle="yes">et al.</italic>, 2017</xref>). Beyond cancer, nCV can be used to estimate clock robustness in any context where population scale data are available. In sum, nCV provides a straightforward measure of circadian clock function in the absence of labeled time, the vast majority of all human datasets.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btab731_Supplementary_Data</label>
      <media xlink:href="btab731_supplementary_data.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>We thank Dr Andrew Liu, Dr Eric Zhang and Dr Rafael Irizarry for helpful discussions about circadian amplitude. We thank Dr Ron Anafi for discussing these issues.</p>
    <sec>
      <title>Funding</title>
      <p>This work was supported by the National Cancer Institute [1R01CA227485-01A1 to Ron Anafi and J.B.H.]; National Institute of Neurological Disorders and Stroke [5R01NS054794-13 to Andrew Liu and J.B.H.]; and the National Heart, Lung and Blood Institute [5R01HL138551-02 to Eric Bittman and J.B.H.].</p>
    </sec>
    <sec>
      <title>Data availabilty</title>
      <p>The datasets were derived from sources in the public domain: [GEO, <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/</ext-link>] and [FireBrowse, <ext-link xlink:href="http://firebrowse.org/" ext-link-type="uri">http://firebrowse.org/</ext-link>].</p>
      <p><italic toggle="yes">Conflict of Interest:</italic> none declared.</p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btab731-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anafi</surname><given-names>R.C.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2017</year>) <article-title>CYCLOPS reveals human transcriptional rhythms in health and disease</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>, <volume>114</volume>, <fpage>5312</fpage>–<lpage>5317</lpage>.<pub-id pub-id-type="pmid">28439010</pub-id></mixed-citation>
    </ref>
    <ref id="btab731-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bae</surname><given-names>K.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2001</year>) <article-title>Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock</article-title>. <source>Neuron</source>, <volume>30</volume>, <fpage>525</fpage>–<lpage>536</lpage>.<pub-id pub-id-type="pmid">11395012</pub-id></mixed-citation>
    </ref>
    <ref id="btab731-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bunger</surname><given-names>M.K.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2000</year>) <article-title>Mop3 is an essential component of the master circadian pacemaker in mammals</article-title>. <source>Cell</source>, <volume>103</volume>, <fpage>1009</fpage>–<lpage>1017</lpage>.<pub-id pub-id-type="pmid">11163178</pub-id></mixed-citation>
    </ref>
    <ref id="btab731-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>C.-Y.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <article-title>Effects of aging on circadian patterns of gene expression in the human prefrontal cortex</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>, <volume>113</volume>, <fpage>206</fpage>–<lpage>211</lpage>.<pub-id pub-id-type="pmid">26699485</pub-id></mixed-citation>
    </ref>
    <ref id="btab731-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gonze</surname><given-names>D.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2002</year>) <article-title>Robustness of circadian rhythms with respect to molecular noise</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>, <volume>99</volume>, <fpage>673</fpage>–<lpage>678</lpage>.<pub-id pub-id-type="pmid">11792856</pub-id></mixed-citation>
    </ref>
    <ref id="btab731-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kiessling</surname><given-names>S.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2017</year>) <article-title>Enhancing circadian clock function in cancer cells inhibits tumor growth</article-title>. <source>BMC Biol</source>., <volume>15</volume>, <fpage>13</fpage>.<pub-id pub-id-type="pmid">28196531</pub-id></mixed-citation>
    </ref>
    <ref id="btab731-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kume</surname><given-names>K.</given-names></string-name></person-group>  <etal>et al</etal> (<year>1999</year>) <article-title>mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop</article-title>. <source>Cell</source>, <volume>98</volume>, <fpage>193</fpage>–<lpage>205</lpage>.<pub-id pub-id-type="pmid">10428031</pub-id></mixed-citation>
    </ref>
    <ref id="btab731-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sancar</surname><given-names>A.</given-names></string-name>, <string-name><surname>Van Gelder</surname><given-names>R.N.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Clocks, cancer, and chronochemotherapy</article-title>. <source>Science</source>, <volume>371</volume>, <fpage>eabb0738</fpage>.<pub-id pub-id-type="pmid">33384351</pub-id></mixed-citation>
    </ref>
    <ref id="btab731-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Savvidis</surname><given-names>C.</given-names></string-name>, <string-name><surname>Koutsilieris</surname><given-names>M.</given-names></string-name></person-group> (<year>2012</year>) <article-title>Circadian rhythm disruption in cancer biology</article-title>. <source>Mol. Med</source>., <volume>18</volume>, <fpage>1249</fpage>–<lpage>1260</lpage>.<pub-id pub-id-type="pmid">22811066</pub-id></mixed-citation>
    </ref>
    <ref id="btab731-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shilts</surname><given-names>J.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>Evidence for widespread dysregulation of circadian clock progression in human cancer</article-title>. <source>PeerJ</source>, <volume>6</volume>, <fpage>e4327</fpage>.<pub-id pub-id-type="pmid">29404219</pub-id></mixed-citation>
    </ref>
    <ref id="btab731-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ukai</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ueda</surname><given-names>H.R.</given-names></string-name></person-group> (<year>2010</year>) <article-title>Systems biology of mammalian circadian clocks</article-title>. <source>Annu. Rev. Physiol</source>., <volume>72</volume>, <fpage>579</fpage>–<lpage>603</lpage>.<pub-id pub-id-type="pmid">20148689</pub-id></mixed-citation>
    </ref>
    <ref id="btab731-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>G.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020a</year>) <article-title>A population-based gene expression signature of molecular clock phase from a single epidermal sample</article-title>. <source>Genome Med</source>., <volume>12</volume>, <fpage>73</fpage>.<pub-id pub-id-type="pmid">32825850</pub-id></mixed-citation>
    </ref>
    <ref id="btab731-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>G.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020b</year>) <article-title>Genome-wide studies of time of day in the brain: design and analysis</article-title>. <source>Brain Sci. Adv</source>., <volume>6</volume>, <fpage>92</fpage>–<lpage>105</lpage>.</mixed-citation>
    </ref>
    <ref id="btab731-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ye</surname><given-names>Y.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>The genomic landscape and pharmacogenomic interactions of clock genes in cancer chronotherapy</article-title>. <source>Cell Syst</source>., <volume>6</volume>, <fpage>314</fpage>–<lpage>328.e2</lpage>.<pub-id pub-id-type="pmid">29525205</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
